New Research Shows How Financial Engineering Could Make Life-Saving Drugs More Available and Affordable (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)

At a time when breakthrough therapies for certain cancers, hepatitis C, and rare diseases remain out of reach for many patients due to their prohibitive cost, new research by Dana-Farber Cancer Institute and MIT Sloan School researchers offers a potential remedy: securitized consumer healthcare loans (HCLs). Dana-Farber/Brigham and Women's Cancer Center/Massachusetts General Hospital Cancer Center is one of the 26 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news